Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors
Clinical trial NCT06220318 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06220318
- Sponsor
- Fujian Haixi Pharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-19
- Primary completion
- 2026-08-30
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.